Establishing new bioanalytical laboratory assays requires a major investment of effort and capital. You can let Cellular Technology Limited’s (CTL) team of experts handle the details for you, to save time and money.
CTL has been providing contract research services to government agencies, major pharmaceutical and biotechnology companies, and academic institutions for more than 15 years. In 2007, CTL has chosen to serve as an ELISPOT reference laboratory by the Immune Tolerance Network and the Sabin Vaccine Institute’s Cancer Vaccine Consortium.
In addition, CTL has been awarded multiple infinite delivery / indefinite-quantity (IDIQ) contracts by the US National Institutes of Health (NIH) for the development and validation of human and animal models for infectious diseases and biodefense applications.